Presentation Information
[P-57]遺伝子発現変動に基づくSARS-CoV-2ワクチンのモダリティ別反応原性の評価とin vitro評価法の検討
*Kou Hiraga1, Haruka Momose1, Mieko Ishii1, Keiko Imai1, Junichi Maeyama1, Kazumi Nakano1, Yohei Seki1, Madoka Kuramitsu1, Takuo Mizukami1 (1. Center for Next-Generation Biologics Research, National Institute of Infectious Diseases, Japan Institute for Health Security)